A standard database for drug repositioning
暂无分享,去创建一个
[1] Tony Tse,et al. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination , 2015, PloS one.
[2] Jagadeesh Patchala,et al. Concept Modeling-based Drug Repositioning , 2015, AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science.
[3] Isaac S. Kohane,et al. ksRepo: a generalized platform for computational drug repositioning , 2016, BMC Bioinformatics.
[4] Ying Li,et al. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality , 2014, J. Am. Medical Informatics Assoc..
[5] Michael Schroeder,et al. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning. , 2015, Methods.
[6] R. Sharan,et al. PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.
[7] Eric K. Neumann,et al. Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships , 2009, BMC Bioinformatics.
[8] Ricardo Pietrobon,et al. The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty , 2012, PloS one.
[9] Peter Dalgaard,et al. R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .
[10] Wyeth W. Wasserman,et al. Quantitative biomedical annotation using medical subject heading over-representation profiles (MeSHOPs) , 2012, BMC Bioinformatics.
[11] Khader Shameer,et al. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. , 2015, Current topics in medicinal chemistry.
[12] D. Madigan,et al. Medication-Wide Association Studies , 2013, CPT: pharmacometrics & systems pharmacology.
[13] Olivier Bodenreider,et al. The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..
[14] Allen Kent,et al. Machine literature searching VIII. Operational criteria for designing information retrieval systems , 1955 .
[15] S. Ferrari,et al. Author contributions , 2021 .
[16] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[17] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[18] Zongliang Yue,et al. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates , 2015, BMC Bioinformatics.
[19] Dirk C. Keene. Acknowledgements , 1975 .
[20] Patrick B. Ryan,et al. Validation of a common data model for active safety surveillance research , 2012, J. Am. Medical Informatics Assoc..
[21] Antonio Jimeno-Yepes,et al. The NLM Medical Text Indexer System for Indexing Biomedical Literature , 2013, BioASQ@CLEF.
[22] Raul Rodriguez-Esteban,et al. A Drug-Centric View of Drug Development: How Drugs Spread from Disease to Disease , 2016, PLoS Comput. Biol..
[23] Chirag J. Patel,et al. A review of validation strategies for computational drug repositioning , 2016, Briefings Bioinform..
[24] Tudor I. Oprea,et al. DrugCentral: online drug compendium , 2016, Nucleic Acids Res..
[25] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[26] Zhiyong Lu,et al. A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..